Ivermectin; authorize pharmacists to provide to adults pursuant to collaborative pharmacy practice agreement.
Impact
If enacted, this bill will substantially alter the regulatory framework surrounding the dispensing of ivermectin in Mississippi. The Board of Pharmacy is tasked with creating rules that will standardize the procedures for pharmacists, ensuring consistent patient care and information dissemination. The act also proposes the option for pharmacists to charge administrative fees for their services, which may incentivize participation while potentially affecting medication accessibility for patients.
Summary
House Bill 1182 seeks to empower pharmacists to provide ivermectin to patients aged eighteen and older, contingent upon a valid collaborative pharmacy practice agreement. This agreement must include a non-patient-specific prescriptive order and standardized procedures established by authorized practitioners. The bill aims to ensure that when pharmacists dispense ivermectin, they adhere to specific guidelines that encompass risk assessment tools and factual information for patients regarding the medication's use.
Contention
A notable point of contention surrounding HB1182 revolves around the responsibilities and liabilities of pharmacists. The bill provides immunity to pharmacists and practitioners from civil liability and disciplinary actions, provided they act in good faith. Critics may argue that this immunity could lead to less scrutiny of prescribing practices and a potential decline in the quality of care. Supporters, however, contend that removing liability fears may encourage pharmacists to practice their professional judgment without hesitation, ultimately benefiting patient access to necessary medications.